Claudio Piersimoni

4.0k total citations
65 papers, 2.3k citations indexed

About

Claudio Piersimoni is a scholar working on Epidemiology, Infectious Diseases and Surgery. According to data from OpenAlex, Claudio Piersimoni has authored 65 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Epidemiology, 54 papers in Infectious Diseases and 21 papers in Surgery. Recurrent topics in Claudio Piersimoni's work include Mycobacterium research and diagnosis (55 papers), Tuberculosis Research and Epidemiology (51 papers) and Infectious Diseases and Tuberculosis (12 papers). Claudio Piersimoni is often cited by papers focused on Mycobacterium research and diagnosis (55 papers), Tuberculosis Research and Epidemiology (51 papers) and Infectious Diseases and Tuberculosis (12 papers). Claudio Piersimoni collaborates with scholars based in Italy, United States and Spain. Claudio Piersimoni's co-authors include Claudio Scarparo, Domenico Nista, Enrico Tortoli, Stefano Bornigia, Paola Cichero, M. T. Simonetti, Giampietro Gesu, Giuseppina De Sio, P Piccoli and Mariuccia Scagnelli and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and Journal of Clinical Microbiology.

In The Last Decade

Claudio Piersimoni

64 papers receiving 2.2k citations

Peers

Claudio Piersimoni
Claudio Piersimoni
Citations per year, relative to Claudio Piersimoni Claudio Piersimoni (= 1×) peers Fernando Alcaide

Countries citing papers authored by Claudio Piersimoni

Since Specialization
Citations

This map shows the geographic impact of Claudio Piersimoni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudio Piersimoni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudio Piersimoni more than expected).

Fields of papers citing papers by Claudio Piersimoni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudio Piersimoni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudio Piersimoni. The network helps show where Claudio Piersimoni may publish in the future.

Co-authorship network of co-authors of Claudio Piersimoni

This figure shows the co-authorship network connecting the top 25 collaborators of Claudio Piersimoni. A scholar is included among the top collaborators of Claudio Piersimoni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudio Piersimoni. Claudio Piersimoni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Piersimoni, Claudio, et al.. (2019). Comparative evaluation of Xpert MTB/RIF and the new Xpert MTB/RIF ultra with respiratory and extra-pulmonary specimens for tuberculosis case detection in a low incidence setting. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases. 15. 100094–100094. 34 indexed citations
2.
Piersimoni, Claudio, Alessandro Mustazzolu, Angelo Iacobino, et al.. (2016). Pyrazinamide susceptibility testing: proposed new standard with the BACTEC<SUP>TM</SUP> MGIT<SUP>TM</SUP> 960 system. The International Journal of Tuberculosis and Lung Disease. 20(12). 1677–1680. 6 indexed citations
3.
Tortoli, Enrico, Cristina Russo, Claudio Piersimoni, et al.. (2012). Clinical validation of Xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosis. European Respiratory Journal. 40(2). 442–447. 242 indexed citations
4.
Piersimoni, Claudio. (2011). Nontuberculous mycobacteria infection in solid organ transplant recipients. European Journal of Clinical Microbiology & Infectious Diseases. 31(4). 397–403. 39 indexed citations
5.
Filia, Antonietta, Antonino Bella, Claudio Piersimoni, et al.. (2011). Tuberculosis in Kindergarten and Primary School, Italy, 2008–2009. Emerging infectious diseases. 17(3). 514–516. 17 indexed citations
6.
Piersimoni, Claudio & Claudio Scarparo. (2009). Extrapulmonary Infections Associated with Nontuberculous Mycobacteria in Immunocompetent Persons. Emerging infectious diseases. 15(9). 1351–1358. 187 indexed citations
7.
Piersimoni, Claudio & Claudio Scarparo. (2009). Extrapulmonary Infections Associated with Nontuberculous Mycobacteria in Immunocompetent Persons. Emerging infectious diseases. 15(9). 1351–1358. 7 indexed citations
8.
Piersimoni, Claudio, C Lacchini, Valeria Penati, et al.. (2007). Validation of the agar proportion and 2 liquid systems for testing the susceptibility of Mycobacterium tuberculosis to moxifloxacin. Diagnostic Microbiology and Infectious Disease. 57(3). 283–287. 7 indexed citations
9.
Piersimoni, Claudio, et al.. (2005). Clinical suspicion as a primary guidance to use commercial amplification tests for rapid diagnosis of pulmonary tuberculosis. Diagnostic Microbiology and Infectious Disease. 53(3). 195–200. 2 indexed citations
10.
Migliori, Giovanni Battista, Rosella Centis, Lanfranco Fattorini, et al.. (2003). Monitoring the quality of laboratories and the prevalence of resistance to antituberculosis drugs: Italy, 1998–2000. European Respiratory Journal. 21(1). 129–134. 10 indexed citations
11.
Piersimoni, Claudio, Claudio Scarparo, Paola Cichero, et al.. (1999). Multicenter evaluation of the MB-Redox medium compared with radiometric BACTEC system, mycobacteria growth indicator tube (MGIT), and Löwenstein-Jensen medium for detection and recovery of acid-fast bacilli. Diagnostic Microbiology and Infectious Disease. 34(4). 293–299. 16 indexed citations
12.
Tortoli, Enrico, M. Tronci, Valeria Penati, et al.. (1997). Multicenter evaluation of mycobacteria growth indicator tube (MGIT) compared with the BACTEC radiometric method, BBL biphasic growth medium and Löwenstein—Jensen medium. Clinical Microbiology and Infection. 3(4). 468–473. 13 indexed citations
13.
Piersimoni, Claudio, et al.. (1996). In Vitro Anti‐Mycobacterium avium Activity of N‐(2‐Hydroxyethyl)‐1,2‐benzisothiazol‐3(2H)‐one and ‐thione Carbamic Esters. Archiv der Pharmazie. 329(8-9). 421–425. 9 indexed citations
14.
Fattorini, Lanfranco, Xiao Yan, Enrico Tortoli, et al.. (1996). Type Frequency and Antimicrobial Susceptibility ofMycobacterium avium-intracellulareComplex Strains Isolated in Italy from AIDS and Non-AIDS Patients. Journal of Chemotherapy. 8(1). 37–42. 21 indexed citations
15.
Luzzi, Ida, Antonello Covacci, Stefano Censini, et al.. (1996). Detection of a Vacuolating Cytotoxin in Stools from Children with Diarrhea. Clinical Infectious Diseases. 23(1). 101–106. 13 indexed citations
16.
Piersimoni, Claudio, Enrico Tortoli, Maria Teresa Mascellino, et al.. (1995). Activity of seven antimicrobial agents, alone and in combination, against AIDS-associated isolates of Mycobacterium avium complex. Journal of Antimicrobial Chemotherapy. 36(3). 497–502. 12 indexed citations
17.
Tortoli, Enrico, et al.. (1994). Evaluation of a commercial DNA probe assay for the identification ofMycobacterium kansasii. European Journal of Clinical Microbiology & Infectious Diseases. 13(3). 264–267. 13 indexed citations
18.
Piersimoni, Claudio, et al.. (1992). In Vitro Activity of the New Quinolone Lomefloxacin against Mycobacterium tuberculosis. American Review of Respiratory Disease. 146(6). 1445–1447. 14 indexed citations
19.
Piersimoni, Claudio, et al.. (1991). MIXED MYCOBACTERIAL INFECTION OF CERVICAL LYMPH NODES. The Pediatric Infectious Disease Journal. 10(7). 544–544. 5 indexed citations
20.
Piersimoni, Claudio, et al.. (1990). Rapid presumptive phenospecies identification of mesophilic aeromonads by testing for suicidal activity. European Journal of Clinical Microbiology & Infectious Diseases. 9(8). 608–610. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026